Doctor of Dentistry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Howard Glazer

Dentist, General Practice Fort Lee, NJ Doctor of Dentistry

NPI 1952303000 CMS profile 133202

810 Abbott Blvd, Fort Lee, NJ 07024

Open in the dashboard

General payments

$635,615

346 records reported · program years 2019–2025

Research payments

$950

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Howard Glazer of Fort Lee, NJ is reported in the CMS Open Payments database as having received $635,615 across 346 general payments and $950 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Dentist, General Practice profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $48,965 17
2024 General $76,506 30
2023 General $81,556 52
2022 General $84,509 41
2021 General $97,270 62
2020 General $61,006 34
2020 Research $950 1
2019 General $185,804 110

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Howard Glazer
  • Dentist, General Practice median
  • Middle half of Dentist, General Practice
  • National median

In program year 2025, general payments to Howard Glazer were reported at $48,965. Among 41,122 Dentist, General Practice profiles paid that year, the median was $75 and the middle half received between $27 and $200.

Show as a table
Year Howard Glazer Dentist, General Practice median Middle half National median
2019 $185,804 $61 $23–$158 $163
2020 $61,006 $73 $24–$142 $114
2021 $97,270 $75 $25–$184 $132
2022 $84,509 $75 $27–$198 $149
2023 $81,556 $77 $28–$200 $160
2024 $76,506 $74 $27–$187 $164
2025 $48,965 $75 $27–$200 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Pulpdent Corporation $90,650 7 payments
  2. Shofu Dental Corp $85,750 7 payments
  3. SS White Burs, Inc. $72,286 41 payments
  4. GC America Inc. $58,167 44 payments
  5. Ivoclar Vivadent, Inc. $50,724 23 payments
  6. Bisco, Inc. $47,751 12 payments
  7. DMG America LLC $41,198 56 payments
  8. Septodont Inc. $39,795 33 payments
  9. Tokuyama Dental America Inc. $35,500 25 payments
  10. VOCO America Inc. $27,200 16 payments
  11. Other $86,594 82 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Honoraria $379,397 230 payments
  2. Consulting Fee $123,812 29 payments
  3. Food and Beverage $55,955 26 payments
  4. Compensation for serving as faculty or as a speaker for a medical education program $35,295 10 payments
  5. Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program $14,800 12 payments
  6. Education $9,473 17 payments
  7. Gift $8,065 13 payments
  8. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,980 6 payments
  9. Long term medical supply or device loan $1,950 1 payment
  10. Travel and Lodging $1,887 2 payments
Products named General payments · program years 2019–2025
  1. SS White $72,286 41 payments
  2. LUXATEMP $19,900 28 payments
  3. EXAlence Restorative $19,620 11 payments
  4. EXALENCE Restorative $19,000 7 payments
  5. GC FujiCEM 2 $15,500 7 payments
  6. IBOND UNIVERSAL & IBOND CERAMIC PRIMER $14,500 15 payments
  7. BIODENTINE $12,300 11 payments
  8. CERAMIR BIOCERAMIC IMPLANT CEMENT QUIKCAP $11,000 9 payments
  9. CERAMIR RESTORE QUIKCAP $11,000 9 payments
  10. CERAMIR CROWN & BRIDGE QUIKCAP $11,000 9 payments
  11. Other $260,924 237 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Pulpdent Corporation $950 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

18

Median for Dentist: 47

Drug cost

$73

Median for Dentist: $159

Branded share of claims

0%

Median for Dentist: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Amoxicillin Generic 18 $73

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 110,731 Part D prescribers listed as Dentist; they describe a distribution and say nothing about conduct.

Records

347 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dentist, General Practice in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record